New Results
DeepSTARR predicts enhancer activity from DNA sequence and enables the de novo design of enhancers
View ORCID ProfileBernardo P. de Almeida, Franziska Reiter, Michaela Pagani, View ORCID ProfileAlexander Stark
doi: https://doi.org/10.1101/2021.10.05.463203
Bernardo P. de Almeida
1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, Vienna, Austria
2Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, A-1030, Vienna, Austria
Franziska Reiter
1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, Vienna, Austria
2Vienna BioCenter PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, A-1030, Vienna, Austria
Michaela Pagani
1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, Vienna, Austria
Alexander Stark
1Research Institute of Molecular Pathology (IMP), Vienna BioCenter (VBC), Campus-Vienna-Biocenter 1, Vienna, Austria
3Medical University of Vienna, Vienna BioCenter (VBC), Vienna, Austria
Posted October 07, 2021.
DeepSTARR predicts enhancer activity from DNA sequence and enables the de novo design of enhancers
Bernardo P. de Almeida, Franziska Reiter, Michaela Pagani, Alexander Stark
bioRxiv 2021.10.05.463203; doi: https://doi.org/10.1101/2021.10.05.463203
Subject Area
Subject Areas
- Biochemistry (9118)
- Bioengineering (6759)
- Bioinformatics (23956)
- Biophysics (12107)
- Cancer Biology (9505)
- Cell Biology (13746)
- Clinical Trials (138)
- Developmental Biology (7618)
- Ecology (11669)
- Epidemiology (2066)
- Evolutionary Biology (15482)
- Genetics (10622)
- Genomics (14302)
- Immunology (9472)
- Microbiology (22810)
- Molecular Biology (9083)
- Neuroscience (48903)
- Paleontology (355)
- Pathology (1479)
- Pharmacology and Toxicology (2566)
- Physiology (3829)
- Plant Biology (8320)
- Synthetic Biology (2294)
- Systems Biology (6176)
- Zoology (1297)